Brown Brothers Harriman & CO Takeda Pharmaceutical CO LTD Transaction History

Brown Brothers Harriman & CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$12.8 - $28.65 $3,660 - $8,193	286 Added 29.04%	1,271 $16,000
Q2 2022 Aug 11, 2022	SELL	$13.12 - $15.03 $83,062 - $95,154	-6,331 Reduced 86.54%	985 $14,000
Q1 2022 May 13, 2022	BUY	$13.54 - $15.35 $99,058 - $112,300	7,316 New	7,316 $105,000
Q3 2021 Nov 15, 2021	SELL	$16.3 - $17.26 $24,743 - $26,200	-1,518 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$16.55 - $18.64 $8,324 - $9,375	503 Added 49.56%	1,518 $26,000
Q1 2021 May 13, 2021	SELL	$16.71 - $19.9 $2,055 - $2,447	-123 Reduced 10.81%	1,015 $19,000
Q2 2020 Aug 13, 2020	SELL	$14.59 - $19.5 $1,590 - $2,125	-109 Reduced 8.74%	1,138 $20,000
Q1 2020 May 15, 2020	BUY	$13.02 - $20.31 $16,235 - $25,326	1,247 New	1,247 $19,000
Q4 2019 Feb 14, 2020	SELL	$16.88 - $20.83 $6,279 - $7,748	-372 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$16.15 - $17.99 $6,007 - $6,692	372 New	372 $6,000
Q2 2019 Aug 14, 2019	SELL	$16.58 - $20.49 $2,138 - $2,643	-129 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $1,670 - $2,152	100 Added 344.83%	129 $3,000
Q4 2018 Feb 14, 2019	BUY	$15.64 - $21.1 $453 - $611	29 New	29 $0

338

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

Stay updated on Brown Brothers Harriman & CO with notifications on news.